All lobbying filings

VENABLE LLP

VENABLE LLP filed a Q3 report for GENEOSCOPY on October 20, 2026, reporting $20,000 in lobbying income.

Lobbying for GENEOSCOPY · Life sciences company

All filings by VENABLE LLP · Everything GENEOSCOPY has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

Missouri

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Increasing access to colorectal cancer screening USPSTF colorectal cancer screening guidelines Medicare Quality Measures Commercial coverage of colorectal cancer screening

Budget/Appropriations

FY 2027 LHHS Appropriations regarding colorectal cancer screening

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.